Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 40 is a processed pseudogene located within the human genome that originated from retrotransposition of the messenger RNA for ribosomal protein L12 (RPL12)[5]. Unlike its parental gene, RPL12P40 does not encode a functional protein and is classified as a molecular fossil of the ribosomal protein gene family. Such pseudogenes are dispersed throughout the genome and do not participate in ribosome assembly, protein synthesis, or any cellular functions. Pseudogenes like RPL12P40 may decay over evolutionary time or acquire silent mutations and are not considered therapeutic targets, nor do they have known pathogenic, biomarker, or pharmacological roles[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 40 (RPL12P40).